Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Homografts: a review.

Helmut Gulbins1, E Kreuzer, B Reichart

  • 1Dept. of Cardiac Surgery, Univ. Hospital Grosshadern, LMU Munich, D-81366 Munich, Germany. H.Gulbins@hch.med.uni-muenchen.de

Expert Review of Cardiovascular Therapy
|March 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postoperative Heparin-Mediated Extracorporeal Low-Density Lipoprotein Fibrinogen Precipitation Aphaeresis Prevents Early Graft Occlusion after Coronary Artery Bypass Grafting.

Surgery journal (New York, N.Y.)·2017
Same author

LEA29Y expression in transgenic neonatal porcine islet-like cluster promotes long-lasting xenograft survival in humanized mice without immunosuppressive therapy.

Scientific reports·2017
Same author

A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list.

Clinical research in cardiology : official journal of the German Cardiac Society·2015
Same author

Xenotransplantation of porcine islet cells as a potential option for the treatment of type 1 diabetes in the future.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
Same author

Levosimendan for primary graft failure after heart transplantation: a 3-year follow-up.

Transplantation proceedings·2011
Same author

Genetic polymorphisms of TP53 and FAS promoter modulate the progression of coronary artery disease after coronary artery bypass grafting: a gender-specific view.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2011

Homografts offer superior durability and hemodynamics compared to other biological prostheses, making them a good option for younger patients. The Ross-procedure may be better for very young patients due to slower degeneration.

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science

Background:

  • Homografts have been used in clinical practice since 1965, with improved storage and sterilization.
  • Long-term studies show homografts outperform xenogenic prostheses in durability and hemodynamic function.

Purpose of the Study:

  • To review the long-term outcomes, implantation techniques, and patient selection for homograft heart valves.
  • To compare homograft performance with other prosthetic options, including mechanical and xenogenic valves.

Main Methods:

  • Review of clinical data and long-term follow-up studies on homograft valve implantation.
  • Comparison of hemodynamic profiles and thromboembolic event rates between different valve types.
  • Analysis of implantation techniques: subcoronary and mini-root, including the Ross-procedure.

Related Experiment Videos

Main Results:

  • Homografts demonstrate superior durability (40% in situ at 20 years in aortic position) and excellent hemodynamics.
  • Low thromboembolic event rates eliminate the need for lifelong anticoagulation.
  • The mini-root technique is advantageous for endocarditis patients; the Ross-procedure is beneficial for children due to slower autograft degeneration.

Conclusions:

  • Homografts are a viable alternative to mechanical prostheses for younger, active patients due to their hemodynamic benefits and low thromboembolic risk.
  • The Ross-procedure offers advantages over aortic homografts in very young patients, mitigating immunologic response and graft degeneration.
  • Individual patient assessment is crucial for selecting the optimal heart valve prosthesis.